This nationwide Danish register-based cohort study (1996–2023) compared colorectal cancer (CRC) incidence rates in 124,387 IBD patients versus 1,213,641 matched general population comparators, stratified by family history of CRC (number of first-degree relatives affected and age at their CRC diagnosis: <50 or ≥50 years).
IBD patients had a higher overall CRC incidence rate than comparators (IR 1.17 vs. 0.88/1,000 person-years). Within IBD, having ≥2 affected first-degree relatives added 2.69 additional CRC cases/1,000 person-years vs. no family history — the largest risk increment — while early-onset family history added only 0.42/1,000 person-years (95% CI crossing zero). On the absolute scale, family history raised CRC risk similarly in IBD and the general population, except those with no family history, where IBD patients had meaningfully higher incidence.
Register-based design may miss incomplete family history data or misclassified IBD diagnoses; the matched cohort design controls for key variables but residual confounding remains possible; findings are from a single country (Denmark/Sweden), limiting generalizability.
Current guidelines flag family history of *early-onset* CRC for intensified IBD surveillance, but this study shows the biggest absolute CRC risk jump comes from having **≥2 affected relatives** — consider redirecting enhanced surveillance toward IBD patients with multiple affected first-degree relatives rather than solely those with early-onset family history.
Explore related topics